1 |
Ko CH, Kong CK, Tse PWT. Valproic acid and thrombocytopenia: cross-sectional study. Hong Kong Med J 2001;7: 15-21
ScienceOn
|
2 |
Gesundheit B, Kirby M, Lau W, Koren G, Abdelhaleem M. Thrombocytopenia and megakaryocyte dysplasia: an adverse effect of valproic acid treatment. Pediatr Hematol Oncol 2002;24:589-90
DOI
ScienceOn
|
3 |
Kishi T, Fujita N, Kawaguchi H, Ishimae M, Watanabe K, Tanaka T. Bone marrow suppression induced by high dose valproic acid. Arch Dis Child 1994;71;153-5
DOI
ScienceOn
|
4 |
Nam SJ, Lee GJ, Lee KH, Bae EJ, Lee HJ, Park WI. The prevalence and the risk factors of thrombocytopenia in children with convulsive disorders taking valproate. J Korean Child Neurol Soc 2006;14:310-5
|
5 |
Hoffman LM. Sodium valproate and thrombocytopenia. Can Med Assoc J 1982;126;358-9
DOI
PUBMED
|
6 |
Verrotti A, Greco R, Matera V, Altobelli E, Morgese G, Chiarelli F. Platelet count and function in children receiving sodium valproate. Pediatr Neurol 1999;21:611-4
DOI
ScienceOn
|
7 |
May RB, Sunder TR. Hematological manifestations of long- term valproate therapy. Epilepsia 1993;34:1098-101
DOI
ScienceOn
|
8 |
Delgado MR, Riela AR, Mills J, Browne R, Roach S. Thrombocytopenia secondary to high valproate levels in children with epilepsy. J Child Neurol 1994;9:311-4
DOI
ScienceOn
|
9 |
Neophytides AN, Nutt JG, Lodish JR. Thrombocytopenia associated with sodium valproate treatment. Ann Neurol 1979;5:389-90
DOI
ScienceOn
|
10 |
Morris N, Barr RD, Pai KR, Kelton JG. Valproic acid and thrombocytopenia. Can Med Assoc J 1981;125:63-4
PUBMED
|
11 |
Barr RD, Copeland SA, Stockwell ML, Morris N, Kelton JC. Valproic acid and immune thrombocytopenia. Arch Dis Child 1982;57;681-4
DOI
ScienceOn
|
12 |
Sandler RM, Emberson C, Roberts GE, Voak D, Darnborough J, Heely AF. IgM platelet autoantibody due to sodium valproate. Br Med J 1978;2:1683-4
DOI
PUBMED
|
13 |
Eastham RD, Jancer J. Sodium valproate and platelet counts (letter). Br Med J 1980;280;186
PUBMED
|
14 |
Trannel TJ, Ahmed I, Goebert D. Occurrence of thrombocytopenia in psychiatric patients taking valproate. Am J Psychiatry 2001;158:128-30
DOI
ScienceOn
|
15 |
Allarakhia IN, Garofalo EA, Komarynski MA, Robertson PL. Valproic acid and thrombocytopenia in children: a case- controlled retrospective study. Pediatr Neurol 1996;14:303-7
DOI
ScienceOn
|
16 |
von Voss H, Schulte-Berbuhl R, Glöbel U. Side effects of sodium valproate (sodium di-N-propylacetate) on malonyldialdehyde-production and other platelet function tests. Minerva Pediatr 1978;30;1397-404
PUBMED
ScienceOn
|
17 |
Sutor AH, Jesdinsky-Buscher C. Gerinungsvernderungen durch dipropylessigsure (Ergenyl). Med Welt 1974;25:447-9
PUBMED
|
18 |
Smith FR, Boots M. Sodium valproate and bone marrow suppression. Ann Neurol 1980;8:197-9
DOI
ScienceOn
|
19 |
Simon D, Penry JK. Sodium di-N-propylacetate (DPA) in the epilepsy, Epilepsia 1975;16:549-73
DOI
ScienceOn
|